IRIS - Res&Arch Institutional Research Information System - Research & Archive

GIUSTOZZI, MICHELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.373
AS - Asia 1.066
EU - Europa 865
SA - Sud America 217
AF - Africa 21
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.342
SG - Singapore 548
IT - Italia 225
IE - Irlanda 220
CN - Cina 182
BR - Brasile 175
HK - Hong Kong 158
RU - Federazione Russa 143
DE - Germania 86
VN - Vietnam 85
FI - Finlandia 43
GB - Regno Unito 33
SE - Svezia 27
KR - Corea 22
CA - Canada 14
AT - Austria 13
AR - Argentina 12
FR - Francia 12
IN - India 12
MX - Messico 12
NL - Olanda 12
UA - Ucraina 11
PL - Polonia 9
JP - Giappone 8
BE - Belgio 7
TR - Turchia 7
VE - Venezuela 7
ZA - Sudafrica 7
CO - Colombia 6
EC - Ecuador 6
IQ - Iraq 6
LT - Lituania 6
ES - Italia 5
JO - Giordania 5
PK - Pakistan 5
BD - Bangladesh 4
CH - Svizzera 4
EG - Egitto 4
IL - Israele 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CZ - Repubblica Ceca 3
GR - Grecia 3
ID - Indonesia 3
KE - Kenya 3
LB - Libano 3
PE - Perù 3
UZ - Uzbekistan 3
DZ - Algeria 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AZ - Azerbaigian 1
DK - Danimarca 1
ET - Etiopia 1
GP - Guadalupe 1
GT - Guatemala 1
JM - Giamaica 1
LK - Sri Lanka 1
LY - Libia 1
MA - Marocco 1
ML - Mali 1
NZ - Nuova Zelanda 1
PF - Polinesia Francese 1
PS - Palestinian Territory 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 3.545
Salva come PNG Salva come JPEG
Città #
Singapore 364
Chandler 236
Dublin 219
Hong Kong 158
San Mateo 97
Altamura 80
Perugia 71
Santa Clara 64
Ashburn 61
Boardman 60
Beijing 54
Medford 53
Lawrence 52
Princeton 52
Moscow 45
Munich 42
Los Angeles 35
Wilmington 33
Redmond 29
Andover 27
Des Moines 27
New York 26
Dong Ket 25
Ho Chi Minh City 23
Seoul 22
Turku 20
São Paulo 18
The Dalles 18
Hanoi 16
Redwood City 16
Columbus 14
Helsinki 13
Nuremberg 12
Dallas 9
Norwalk 9
Rome 9
Saint Petersburg 9
Shanghai 9
Ancona 8
Chicago 8
Piscataway 8
Tokyo 8
Amsterdam 7
Brussels 7
Denver 7
Falls Church 7
Falkenstein 6
Rio de Janeiro 6
San Paolo di Civitate 6
Warsaw 6
Amman 5
Brooklyn 5
Houston 5
Johannesburg 5
Stockholm 5
Ann Arbor 4
Bexley 4
Brasília 4
Guarulhos 4
Manchester 4
Montreal 4
Mumbai 4
Poplar 4
Quito 4
Seattle 4
Asunción 3
Atlanta 3
Belo Horizonte 3
Buenos Aires 3
Cairo 3
Campina Grande 3
Caracas 3
Chennai 3
Córdoba 3
Hefei 3
Juiz de Fora 3
Lima 3
London 3
Mexico City 3
Milan 3
Mineral de la Reforma 3
Nairobi 3
Olomouc 3
Orem 3
San Francisco 3
San Jose 3
Vienna 3
Baghdad 2
Bismarck 2
Biên Hòa 2
Bogotá 2
Bologna 2
Bolzano 2
Calgary 2
Campinas 2
Caruaru 2
Curitiba 2
Fairfield 2
Fazenda Rio Grande 2
Franca 2
Totale 2.368
Salva come PNG Salva come JPEG
Nome #
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 93
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 91
Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure 89
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 83
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 82
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 81
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 80
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 80
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 77
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 77
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 75
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 74
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 74
Safety of Anticoagulation in Patients Treated with Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 74
Lo studio EINSTEIN CHOICE 74
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 73
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 73
Beyond the guidelines: Novelties, changes and unsolved issues from the 2019 ESC guidelines on pulmonary embolism 73
Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial 72
Grey zones on the use of new oral anticoagulants in atrial fibrillation. Expert opinion 71
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 70
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation 70
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation 69
Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study 69
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 68
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis 67
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 66
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 66
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 63
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 63
Vascular events with immune checkpoint inhibitors in melanoma or non-small cell lung cancer: A systematic review and meta-analysis 61
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis 60
Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer 60
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants 58
The EINSTEIN CHOICE study 57
Treatment of venous thromboembolism in patients with cancer: What news from clinical trials? 57
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 56
Perirectal Hematoma and Intra-Abdominal Bleeding after Stapled Hemorrhoidopexy and STARR—A Proposal for a Decision-Making Algorithm 55
Management of Anticoagulant Treatment and Anticoagulation-Related Complications in Nonagenarians 55
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 52
Ten questions on venous thromboembolism 52
Thrombotic Complications in Patients with COVID-19: Pathophysiological Mechanisms, Diagnosis, and Treatment 52
Total parenteral nutrition-induced Wernicke's encephalopathy after oncologic gastrointestinal surgery 51
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 50
The role of computed tomography angiography 3D imaging in post-operative haemorrhage after groin mesh hernioplasty during anticoagulation therapy 49
Safety of catheter ablation of atrial fibrillation in cancer survivors 48
DOACs in patients with brain cancers: promising but still a long way to go 46
Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE 44
Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism: A case report 43
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism 42
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management 41
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 41
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 40
Thrombolysis in hemodynamically stable patients with acute pulmonary embolism: A meta-analysis 39
ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis 37
Patients with Atrial Fibrillation receiving NOACs: The boundary between appropriate and inappropriate dose 37
The possible clinical impact of a threshold left atrial diameter associated with new AF in ESUS patients 35
Shock and diffuse ST-elevation in a patient with coronavirus disease-2019 disease 33
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 31
Reversal of dabigatran-associated bleeding using idarucizumab: review of the current evidence 29
Acute venous thromboembolism in patients with brain cancer: clinical course 25
Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism 14
Totale 3.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.019
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202164 0 0 0 0 0 15 8 4 3 8 1 25
2021/2022390 1 70 5 9 19 3 6 106 12 39 64 56
2022/2023821 54 190 9 46 58 91 0 38 296 3 27 9
2023/2024334 29 38 21 6 5 0 81 5 12 26 54 57
2024/2025884 9 67 27 62 97 61 29 52 187 62 142 89
2025/2026937 152 122 95 242 265 61 0 0 0 0 0 0
Totale 3.687